Alternative splicing of glutamate transporter EAAT2 RNA in neocortex and hippocampus of temporal lobe epilepsy patients

Epilepsy Research
G HooglandP N E de Graan

Abstract

Altered expression of glutamate transporter EAAT2 protein has been reported in the hippocampus of patients with temporal lobe epilepsy (TLE). Two alternative EAAT2 mRNA splice forms, one resulting from a partial retention of intron 7 (I7R), the other from a deletion of exon 9 (E9S), were previously implicated in the loss of EAAT2 protein in patients with amyotrophic lateral sclerosis. By RT-PCR we studied the occurrence of I7R and E9S in neocortical and hippocampal specimens from TLE patients and non-neurological controls. Both splice forms were found in all neocortical specimens from TLE patients (100% I7R, 100% E9S). This was significantly more than in controls (67% I7R, 60% E9S; P < 0.05). We also detected I7R and E9S in all seven motor cortex post-mortem samples from patients with amyotrophic lateral sclerosis. Within the TLE patient group, both splice variants appeared significantly more in non-sclerotic (100%), than in sclerotic hippocampi (69%, P < 0.05). These data indicate that the epileptic brain, especially that of TLE patients without hippocampal sclerosis, is highly prone to alternative EAAT2 mRNA splicing. Our data confirm that the presence of alternative EAAT2 splice forms is not disease specific.

References

May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Mar 1, 1992·Neurochemical Research·N A JanjuaA Mori
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
Mar 21, 1998·Neuroscience Letters·T MeyerA C Ludolph
Dec 17, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·T MeyerA C Ludolph
Feb 1, 2000·Journal of Neurology·M JacksonK E Morrison
May 23, 2001·Progress in Neurobiology·N C Danbolt
Feb 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Zao-zhong SuPaul B Fisher

❮ Previous
Next ❯

Citations

Feb 6, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Julie FotheringhamSteven Jacobson
Dec 3, 2009·Antioxidants & Redox Signaling·Sergio Rosales-CorralGabriela Lopez-Armas
May 8, 2010·Journal of Neuropathology and Experimental Neurology·Rujin TianJames E Goldman
Oct 24, 2009·Epilepsy Research·Simon Waldbaum, Manisha Patel
Nov 6, 2007·Neuroscience·L T Macnab, D V Pow
May 23, 2007·Neurochemistry International·Amanda L Sheldon, Michael B Robinson
Nov 8, 2006·British Journal of Pharmacology·P M Beart, R D O'Shea
Jan 24, 2006·Neurochemistry International·I W M BosP N E de Graan
May 14, 2014·Epilepsy Research·Mauro DiNuzzoFederico Giove
Mar 3, 2009·Epilepsy & Behavior : E&B·Ingmar Blümcke
Dec 9, 2010·Brain Research·Taku DoiL James Willmore
Apr 29, 2008·Neuron·Jonathon WetheringtonRay Dingledine
Jan 17, 2015·Neuroscience·C SteinhäuserG Carmignoto
Aug 9, 2007·Molecular Psychiatry·T L Lauriat, L A McInnes
Nov 23, 2016·Neurochemical Research·Jan Albrecht, Magdalena Zielińska
May 12, 2020·Frontiers in Cellular Neuroscience·Adam Armada-MoreiraSandra H Vaz
Nov 14, 2007·Neurochemical Research·Christoph MünchThomas Meyer
Feb 9, 2021·Experimental Biology and Medicine·Sheila Ms Sears, Sandra J Hewett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.